comparemela.com

Latest Breaking News On - Medical pharmaceuticals - Page 16 : comparemela.com

$3 34 Billion DNA Data Storage (Cloud, On-Premises) Markets, 2030: Focus on Sequence-based DNA Data Storage, Structure-based DNA Data Storage

/PRNewswire/ The "DNA Data Storage Market by Type (Cloud, On-Premises), Technology (Sequence-based DNA Data Storage, Structure-based DNA Data Storage), End.

South koreaUnited statesLaura woodTechnology analysisData storage solutions to boost marketCompany profilesHelixworks technologies ltdOxford nanopore technologiesBgi group guangdong icpAgilent technologies incBeckman coutler incData storage solutionsTerm archival data preservation solutionsPenetration of big data across industriesThermo fisher scientific incIllumina inc

Demron, the only Anti-Nuclear Radiation Personal Protective Equipment (PPE) by Radiation Shield Technologies (RST)

/PRNewswire/ Demron by Radiation Shield Technologies (RST) is the only true anti-nuclear garment that protects against ionizing radiation, chemical,.

United statesPrnewswire demronRadiation shield technologiesDemron testMedical pharmaceuticalsHealth care amp hospitalsMedical equipmentNew products amp services

SeekIn and OncoInv Collaborate to Expand the Global Accessibility of Multiple Cancer Detection Tests and Bridge Global Disparities in Cancer Care

/PRNewswire/ SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced a strategic collaboration with Oncolnv, a.

Noord hollandCosta ricaPeter kapiteinLive annual congressSeekin incGrant oncolnvRepresent seekinComprehensive rangeCancer detection testsTwelve countriesProvide individualsAffordable cancer detectionAnnual congressHealth care amp hospitalsMedical pharmaceuticals

New Study Finds Significant Impact of Plant-Based Diets on Chronic Kidney Disease Patients

/PRNewswire/ A study published in this month s issue of the National Kidney Foundation American Journal of Kidney Diseases (AJKD) provides new insights into.

United statesSaira amirKevin longinoMirela dobreCaseym rebholzSankard navaneethanNishigandha pradhanCherylam andersonLawrencej appelMichaelj fischerNational kidney foundationamerican journal of diseasesJohns hopkins bloomberg school of public healthDepartment of epidemiologyNational kidney foundationNational kidney foundationamerican journalKidney diseases

Akeso Published Results from CD47 Antibody Ligufalimab in Combination with Azacitidine for Newly Diagnosed Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at ASH 2023

/PRNewswire/ Akeso published two phase Ib clinical results of its innovative CD47 monoclonal antibody ligufalimab (AK117) in combination with azacitidine in.

United statesHong kongPrnewswire akesoAmerican society of hematologyAkeso incAmerican societyInvestigational new drugSummit therapeuticsMain boardStock exchangeMedical pharmaceuticalsHealth care amp hospitalsClinical trials amp medical discoveries

vimarsana © 2020. All Rights Reserved.